Antiplatelet Effect of Ginkgo Diterpene Lactone Meglumine Injection in Acute Ischemic Stroke
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
This study evaluates the addition of Ginkgo Diterpene Lactone Meglumine Injection to aspirin
in the treatment of acute ischemic stroke.Half of patient will receive Ginkgo Diterpene
Lactone Meglumine Injection(25mg once/day D1-D14) and aspirin(100mg once/day D1-D14) in
combination, while the other half will receive aspirin(100mg once/day D1-D14).